Friday, 19 October 2018

Global Therapeutic Landscape of Aromatherapy Market Pipeline Review, 2018

Market Scenario:
Global Aromatherapy Market Information; By Product (Essential Oils (Floral, Citrus, Green/Vegetative, Herbaceous/Camphoraceous, Spicy, Others), Carrier Oils and blended oils), Equipment (Nebulizer Diffuser, Ultrasonic Diffuser, Heat Diffuser), By Application (Tropical, Inhalation, Aerial Diffusion); By Therapeutic Application (Relaxation and Sleep, Pain Management, Skin and Hair Care, Other remedies) - Forecast to 2023
Aromatherapy uses aromatic oils, and other aroma compounds for improving psychological or physical well-being.
The market for aroma therapy is rising due to factors such as large number of people opting for aromatherapy, growing lifestyle industry, non-invasive nature of aromatherapy etc. The modern lifestyle has ushered problems such as sleep disturbances, stress etc. which has inflated the market. Also many essential oils can increase immunity, combat cold and breathing disorders.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3241
The market restraints include increasing stringency of regulations such as indications which a market player has to provide. For example, market players need to mention whether the particular essential oil falls under therapeutic grade or cosmetic grade.
Lack of proper guidelines and toxic nature of essential oils is another barrier. For example, Cineole essential oil is poisonous above the recommended dose and an overdose may cause symptoms such as epigastric burning, nausea, vomiting, dizziness, muscular weakness, rapid heartbeat, feeling of suffocation etc. Also there is no good medical evidence that aromatherapy prevents or cures disease.
Considering all these factors the market for aromatherapy is expected to reach $ 4.3 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 6.18 % during 2017-2023.
Segments:
The global aromatherapy market is segmented on the basis of product. Based on the product, the market has been segmented asessential oils, equipment, application and by therapeutic application. The essential oils segment is sub segmented into floral, citrus, green/vegetative, herbaceous/camphoraceous, spicy and others. The equipment segment is sub segmented into nebulizer diffuser, ultrasonic diffuser and heat diffuser. The application segment is sub segmented into tropical, inhalation and aerial diffusion. The therapeutic application segment is sub segmented into relaxation and sleep, pain management, skin and hair care, and other remedies.
Key players of Global Aromatherapy Market:
Key players profiled in the report are
·         Nu Skin
·         Air Aroma
·         Muji
·         Tree of Life
·         Young Living
·         Zija International
·         dōTERRA
·         NOW Foods
·         Neal’s Yard Remedies
Regional analysis
US accounts for the maximum market share due to high per capita disposable income and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. The European market will be led by France followed by Germany. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3241

Detailed Table of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
12 Appendix
...Continued!

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3241

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Acute Myeloid Leukemia Treatment Market Volume Forecast and Value Chain Analysis 2018

Market Synopsis of Global Acute Myeloid Leukemia Treatment Market
Market Scenario
Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3223
Considering all these factors the market for acute myeloid leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approx 5.3 % during 2017-2023.
Key players of Global Acute Myeloid Leukemia Treatment Market
Key players profiled in the report are Johnson & Johnson, Pfizer Inc., Celgene Corporation, Ambit Biosciences Corporation, Cyclacel Pharmaceuticals Inc. Novartis AG and Sanofi, Bristol Myers Squibb and others.
Segments
The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission.
Regional Analysis
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3223
Detailed Table of Contents:
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3223

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Electronic Pill Market Pipeline Review, 2018- Identify Key Business Opportunities

Market Scenario
The global electronic pill market is expected to reach an approximate CAGR of 15% during the forecast period. The electronic pill is an ingestible capsule that is embedded with sensors and camera. After ingesting the pill, the pill captures several images per second of the gastrointestinal tract which is received by the connected recording device. It is a monitoring system used to monitor temperature, pH, conductivity and dissolved oxygen. Electronic Pills are used for diagnostics of various gastrointestinal tract diseases like colon cancer, colon polyps, gastrointestinal bleeding and other infectious diseases. The increase in preference of non-invasive methods for diagnostics is driving the growth of the market. Moreover, the rising geriatric population, increasing prevalence of gastrointestinal diseases like colorectal cancer, changing lifestyle, increasing unhealthy eating habits, controlled drug delivery and better way of endoscopy procedures are major factors influencing the growth of the market.
According to the American Cancer Society, Inc. in 2017, 27,150 men and 23,110 women had colorectal cancer in the US. Thus, such a high incidence rate of colorectal cancer provides favorable backgrounds for the market growth. Also, growing demand for rapid and precise diagnostics, adoption of advanced technology are the key factors for the market to grow.
However, factors such as bowel obstruction, lack of awareness, capsule retention and high costs are expected to restrict the market growth during the forecast period.
Segmentation
The global electronic pill market is segmented on the basis of Application, Target area, Parts and end user. The electronic pill market, by application, is sub-segmented into Capsule Endoscopy, Drug Delivery, and Patient Monitoring. Target area category includes Oesophagus, Stomach, Small Intestine, and large intestine.
By parts, the market is categorized into biocompatible capsule encasing microsensors, Control chip, Radio transmitter and Power source. On the basis of end-user, the market is segmented into Hospitals, Diagnostic centers, Clinical Research Organizations and Medical Centers.
On the basis of region, the global Electronic Pill market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Global Electronic Pill Market, by Key Players
  • CapsoVision, Inc. (US),
  • Given Imaging Ltd. (Israel),
  • Medimetrics (Mexico),
  • Bio-Images Drug Delivery BDD LTD (UK),
  • Proteus Digital Health (US),
  • Olympus Corporation,
  • Medtronic,
  • Medisafe,
  • JINSHAN Science & Technology,
  • INTROMEDIC
Regional Market Summary
The Electronic Pill market is dominated by North America owing to rising prevalence of gastrointestinal disorders and high R&D investments within this region stimulate market growth. According to the US Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of gastrointestinal disorders influences the market growth in this region.
It is estimated that Europe stood second in the global Electronic Pill market. The increasing prevalence of gastric cancer is driving the growth of this market in Europe. According to the Cancer Research UK in 2015, 6740 new cases of stomach cancer in the U.K and is among the most common prevalent cancer. Thus, increasing prevalence of gastric cancer in Europe drives the market growth. Furthermore, the rapidly growing healthcare sector in Europe is expected to boost the market in this region.
Asia Pacific was projected to be the fastest growing region for the global Electronic Pill market. Key factors such as rising geriatric population, growing patient pool, high incidence of gastrointestinal diseases and developing healthcare infrastructure drive the market in this region. According to the Asian Development Bank (ADB), the geriatric population in Asia is expected to reach 923 million by 2050. This provides favorable backgrounds for the market to grow.
The Middle East and Africa holds the least share in the global Electronic Pill market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investment by private market players in this region can boost the market growth. 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Cell Isolation Market Dynamics, Forecast, Analysis and Supply Demand 2018

Market Snapshot
Cell isolation is viewed as a highly sophisticated process, which has tremendous potential. It is currently used for understanding how cells function. Physicians are also employing cell isolation to find out how cells respond to different diseases and how they are affected by different drugs. In 2017, the global market for cell isolation stood at USD 4, 098.5 Mn and is likely to surpass a valuation of USD 10,500 Mn by the years 2023. While cell isolation is already being considered for treatment purposes, its application is likely to proliferate to various other fields of healthcare science in the future. Cell culture, a process of multiplication of cells to create a cell colony also involves cell isolation.  Other factors that are anticipated to support the growth of the cell isolation market include rising cancer prevalence, increased government funding for cell-based research and advances in cell analysis techniques.
Report Overview
This MRFR market perspective delivers an exhaustive assessment of the current trends in cell isolation process and its market opportunities. It also includes a discussion on the key market dynamics such as drivers and critical restraints that are influencing or disrupting the cell isolation market landscape. A revenue analysis on various sub-markets is also available in research document, which will enable investors to identify revenue pockets that are likely to remain highly lucrative throughout the review period. Major types of product used for cell isolation process covered in the report include consumables and instruments. The overall market sizing based on cell types covers human cells and animal cells. Centrifugation-based cell isolation, surface marker-based cell isolation and filtration-based cell isolation are the major techniques profiled in the report. The currently application areas identified include biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics and therapeutics. A revenue analysis based on primary end-users (research laboratories and institutes, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, and cell banks) is also available.
Report Coverage
Value, Market Share, Player Analysis, supply chain analysis, Porter's five forces model, demand & supply: gap analysis, investment opportunities analysis, pricing analysis, country level break down for product, cell type, technique, application, end-user.
Players Covered
Thermo Fisher Scientific Inc., GE Healthcare, Becton, Dickinson and Company, Beckman Coulter, Merck KGaA, STEMCELL Technologies, Miltenyi Biotec, TERUMO CORPORATION, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG.
Research Methodology
Market Research Future (MRFR) makes comparative assessment of all the market parameters on multiple levels to deliver a macro overview. The projections are made after an in-depth study of various elements such as historical market trends, key developments, and, shifts in consumer behavior. Robust scientific methods are employed for ascertaining the statistical observations. The fail-safe interpretation of data is backed by credible inputs sourced through primary and secondary research which includes interviews with stakeholder across the value chain (CEOs, Business Development Managers, Vice Presidents, etc.), white paper references, research publications, and, reports published by national and international organizations among others. A multi-layer verification process authenticates market forecast and ensures cross-verification of information delivered. Top-down and bottom-up approaches are employed to validate the accuracy of the market size and revenue estimation. MRFR uses innovative and sound analytical algorithms for ensuring the optimum quality of research findings.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Hammertoe Market 2018 Global– Key Players, Size, Trends, Growth- Analysis To 2023

Market Synopsis of Global Hammertoe Market
Market scenario
Hammertoe is a foot deformity due to imbalance in the muscles, tendons or ligaments which normally hold the toe straight. A hammertoe has an abnormal bend in the middle joint of a toe and usually occur in the second, third and fourth toes. Hammertoe can be caused because of wearing wrong type of shoes such as high heels or shoes that are too short or narrow that force the toe into a bent position. Other reasons are foot structure such as bunions or other foot problems, trauma and certain muscle, nerve, or joint damage diseases such as osteoarthritis, rheumatoid arthritis, stroke, Charcot–Marie–Tooth disease, complex regional pain syndrome or diabetes. Changing your footwear and wearing shoe inserts may relieve the pain and pressure of hammertoe but severe cases require surgery to get relief..

The treatment in most cases consists of physical therapy and new shoes with soft, spacious toe boxes and in severe cases, surgery. The patient may also be prescribed toe exercises that can be done at home to stretch and strengthen the toe muscles. Physical exercises such as stretching the toes or picking things by the toes are also effective. In some cases a brace that pushes down on the toes to force them to stretch out their muscles is also prescribed.
Hammertoe can be of two types i.e. flexible hammer toes and rigid hammer toes. Flexible hammer toes are less serious and are still moveable at the joint and are in the developmental stage. Rigid hammer toes is more developed and more serious and can be seen in cases of severe arthritis. Rigid hammer toe are tight, with misaligned and immobile joint, generally requiring surgery.
The treatment of hammertoe include physiotherapy, drug treatment to relieve associated symptoms and surgery. The drawbacks of surgery include risk of infection, associated pain and hospital stay.
The global Hammertoe market is expected to reach US$ 450 million by 2023, and the market is projected to grow at a CAGR of ~ 5.2 % during the forecast period 2017-2023.
Intended Audience
  • Global Hammertoe treatment manufacturers & suppliers
  • Research and development (R&D) companies
  • Hospitals and clinics
  • Academic institutes and universities
Segments:
The global Hammertoe market has been segmented on the basis of type, diagnosis, treatment and end users.
Based on type, the market has been segmented as flexible hammer toes and rigid hammer toes.
Based on the diagnosis, the market has been segmented into physical exam, X-rays and others.
Based on the treatment, the market has been segmented into drugs, orthotic devices, surgery and others.
Based on the end users, the market has been segmented as hospitals & clinics, physiotherapy and orthopedic centers and others.
Regional analysis:The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global Hammertoe market. Also, concentration of major research companies and cancer research sector in the developed countries of this region is adding fuel to the market growth.
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing industrial sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Key Players in the Global Hammertoe Market
Some of key players profiled in the report are BioPro, Instratek, Stryker, Extremity Medical LLC, Arrowhead Medical Device Technologies, LLC, Wright Medical Group N.V., Nextremity Solutions, Inc., Smith & Nephew plc., Biomet, Inc., Acumed and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Desmoid Tumors Market Anticipated To Witness Noteworthy Growth in the Coming Years

Desmoid Tumors Market Top Key Players
Some of key the players in the market are Amgen Inc., Novartis AG, Abbott Laboratories, Bayer AG, AbbVie Inc., Beckman Coulter Inc., Stryker Corporation, Debiopharm Group, F. Hoffmann-La Roche Ltd, and others. 
Market Scenario
Desmoid tumors are also known as desmoid fibromatosis. These benign growths occur very rarely in the general population. Desmoid tumor usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. The term desmoid was derived from the Greek word desmos, which means tendonlike. Desmoid tumors appear as well-differentiated, and firm overgrowths of fibrous tissue. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors.

On molecular level, desmoid tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological differential diagnosis is difficult.
According to the Desmoid Rare Foundation, individuals within the age group of 15 and 60 are more likely to get affected by this condition. It is also stated that the condition is more prevalent in women than in men (2:1).
For the diagnosis of desmoid tumor there are many non-invasive methods available to detect desmoid tumor which include ultrasound, MRI scan, and CT scan. The actual diagnosis of this tumor can be made only after examining a small piece of the tumor by a trained pathologist.
The symptoms of desmoid tumors include a painless swelling or lump, pain and obstruction of the bowels, limping, pain caused by compressed nerves or muscles, and others.
The most commonly used treatment options for desmoid tumors are anti-inflammatory medication, Chemotherapy, Hormone therapy, and surgery among others. Various new therapies are under investigation such as Angiogenesis inhibitors, and Chemotherapy agents. As mutations in the CTNNB1 gene is found to be most commonly occurring in desmoid tumor. So, it is expected that very soon mutation analysis be used to predict the risk of recurrence and to aid in designing individual therapies.
Notably, the market is expected to expand in the near future due to rising demand of effective chemotherapeutic agents, high unmet needs of current treatment, and increase in research and development expenditure.
Despite these drivers, there are some issues associated with desmoid tumors market. High cost of treatment & management of desmoid tumors and related disorders, and lack of infrastructure in the middle and low income countries may hamper the growth of the market.
It is estimated that desmoid tumors market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.
Segmentation
The desmoid tumors market is segmented on the basis of diagnosis, treatment, and end-user.
On the basis of diagnosis, market is segmented into biopsy, electron microscopic examination, immunohistochemical analysis, others
On the basis of treatment, market is classified into surgery, radiation therapy, anti-inflammatory medication, hormone therapy, chemotherapy, novel molecular-targeted therapy, others. Novel molecular-targeted therapy is further segmented into gleevec based therapy, and sorafenib based therapy
On the basis of end-user, market is segmented into hospital, clinics, and others. 

Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Nausea Medicine Market Trends, Size and Growth Analysis 2018 To 2023

Market Synopsis of the Global Nausea Medicine Market

Nausea is a state of stomach distress with an urge to vomit. Common indications of nausea are motion sickness, seasickness, medication and chemotherapy. Stomach ulcers can also cause nausea. Medications and proper dietary habits can treat nausea.
Rising prevalence of gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), and viral gastroenteritis, and availability of a wide range of treatment options drive the market growth. Furthermore, changing lifestyle and dietary habits also influence the market.
The global nausea medicine market is expected to grow at a CAGR of 7.2% during the forecast period.
Key Players in the Global Nausea Medicine Market     
Some of the key players in this market are Merck & Co., Inc. (U.S.), Sanofi (France), TESARO, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer (U.S.), GlaxoSmithKline (U.S.), ANI Pharmaceuticals, Inc. (U.S.).
Segments                                                                                                                                            
The global nausea medicine market is segmented on the basis of type, mode of administration, indication and end user.
On the basis of type, market is segmented into antacids, antagonists, anti-anxiety drugs, steroids, Cannabinoids and Others.
Antacids are further segmented into serotonin (5-HT3) antagonists, NK-1 antagonists and dopamine antagonists.
On the basis of mode of administration, the market is segmented into IVs, tablets and others.
On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication, chemotherapy and others.
On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies and others.
Regional Analysis of the Global Nausea Medicine Market                    
America is the largest market for nausea medicine owing to rising prevalence of gastrointestinal diseases such as GERD drive the market. Furthermore, according to an article published in the “The Journal of Pediatrics” the prevalence of nausea is founding to be increasing among school going children. It also stated the Functional Gastrointestinal Disorders (FGIDs) are frequently associated with nausea. Prevalence of viral gastroenteritis is found to be increasing in the U.S., especially among the pediatric population. According to the Center for Disease Control and Prevention (CDC), each year in the United States, there are nearly 19 to 21 million cases of acute gastroenteritis. Furthermore the prevalence of acute gastrointestinal diseases is found to be high in Canada.
Europe is the second largest market for nausea medicine which exhibits growth opportunities owing to the high prevalence of nausea and vomiting among pregnant women whose population is found to be increasing. Furthermore, there is an extensive demand for the diagnosis and treatment of nausea, especially among pregnant women which will influence the market growth in Europe. Additionally, prevalence of chemotherapy induced nausea is found to be increasing steadily in many parts for the Europe in the last few years. This will further increase the demand for nausea medicine in Europe.
In Asia Pacific, the market is expected grow at the fastest rate owing to changing lifestyle and increasing geriatric population fuel the market growth. Furthermore, viral gastritis and gastric ulcer are found to be prevalent among the Asian Population.  However, presence of misbranded and spurious drugs may restrain the market growth in Asia Pacific.
The Middle East & Africa also show a steady rise in the market owing to rising prevalence of chemotherapy induced nausea.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Comments (Atom)